Debut Plus

₹1.03

▼ -0.01 -0.96%

17 Jul 2026

BSE Listed

Genpharmasec Limited (531592)

Volume: 2,30,954Avg Vol 1W: 6,55,117Avg Vol 1M: 3,63,73752W Range:₹0.75₹2.2
BSE www.genpharmasec.com
Key Ratios
Checked just now
Market Cap₹57 Cr
Current Price₹1.03
Previous Close₹1.04
High / Low (52w)₹2.2 / ₹0.75
Volume2,30,954
Avg Vol (1W)6,55,117
Avg Vol (1M)3,63,737
Stock P/E34.33
Book Value₹1.2
Dividend Yield0%
ROE241.95%
ROA40.54%
Revenue (TTM)—
Revenue Growth—
Profit Margin31.44%
Total Debt—
Shares Outstanding55 Cr
Face Value—
EPS (TTM)₹0.03
P/B0.86
Debt / Equity0.07
50 DMA₹1.14
200 DMA₹1.31
Day change-0.96%
Price Chart
₹1.03▼ 49.51% · 1Y
₹3₹141.3L
2025-07-17
2026-07-17

20-day avg volume: 3.8L shares

Pros
  • Healthy return on equity of 241.9%.
  • Company is almost debt-free.
  • Revenue grew 18% YoY.
  • Stock trades below its book value.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹5 Cr₹6 Cr₹8 Cr₹14 Cr₹12 Cr₹33 Cr₹40 Cr₹55 Cr
EBITDA₹1 Cr₹1 Cr₹1 Cr₹0 Cr₹1 Cr₹-1 Cr₹-1 Cr₹2 Cr
Net Profit₹0 Cr₹1 Cr₹1 Cr₹0 Cr₹1 Cr₹-1 Cr₹-1 Cr₹1 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2023Mar 2024Mar 2025
Revenue₹26 Cr₹31 Cr₹37 Cr
EBITDA₹0 Cr₹1 Cr₹2 Cr
Net Profit₹1 Cr₹0 Cr₹1 Cr
EPS0.04-0.010.02
Balance Sheet
MetricMar 2023Mar 2024Mar 2025
Total Assets₹20 Cr₹71 Cr₹80 Cr
Total Liabilities₹5 Cr₹7 Cr₹15 Cr
Equity₹15 Cr₹65 Cr₹65 Cr
Total Debt———
Cash Flow
MetricMar 2023Mar 2024Mar 2025
Operating₹-3 Cr₹-3 Cr₹3 Cr
Investing₹0 Cr₹-28 Cr₹-15 Cr
Financing₹3 Cr₹48 Cr₹-1 Cr
Free Cash Flow₹-3 Cr₹-3 Cr₹3 Cr
Shareholding
Promoter 29.98% Institutions 0% Public 70.02%
Efficiency & Working Capital
ROCE2.2%
Interest Coverage5.2
Dividend Payout—
Debtor Days147 d
Inventory Days89 d
Payable Days89 d
Cash Conversion Cycle147 d
Working Capital Days236 d
Shareholding Details

As of 2026-06-30

Promoter30%
FII0%
DII0%
Institutions0%
Public70%
Promoter Pledge0%
No. of Shareholders1,01,134
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Feb 2024Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters60%30%30%30%30%30%30%30%30%30%30%30%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public40%70%70%70%70%70%70%70%70%70%70%70%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders89,4381,05,6931,08,1371,08,2201,05,8381,09,2061,09,0801,07,6021,05,8041,04,0211,02,2521,01,134
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503————
Major Shareholders (>1%)
NameCategoryStakeShares
Sneha SadhwaniShareholding of Promoter and Promoter Group16.8%9.30 Cr
Rajesh SadhwaniShareholding of Promoter and Promoter Group13.2%7.30 Cr
Rushabh Sevantilal SanghaviPublic Shareholding4.4%2.45 Cr
Sadashiv Kanyana ShettyPublic Shareholding2.1%1.14 Cr
Yogeshkumar Rasiklal SanghaviPublic Shareholding1.8%97,93,367
Vishesh Mahesh NihalaniPublic Shareholding1.5%84,00,100
L7 Hitech Private LimitedPublic Shareholding1.2%64,84,159
Narendra Chhaganlal SolankiPublic Shareholding1.1%60,09,409
Nimesh Shambhulal JoshiPublic Shareholding1%55,68,556
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Sneha Sadhwani00%2026-06-30
Rajesh Sadhwani00%2026-06-30
Nimesh Shambhulal Joshi00%2026-06-30
Narendra Chhaganlal Solanki00%2026-06-30
Vishesh Mahesh Nihalani00%2026-06-30
Yogeshkumar Rasiklal Sanghavi00%2026-06-30
Sadashiv Kanyana Shetty00%2026-06-30
Rushabh Sevantilal Sanghavi00%2026-06-30
L7 Hitech Private Limited00%2026-06-30
Sneha Sadhwani00%2026-03-31
Rajesh Sadhwani00%2026-03-31
Nimesh Shambhulal Joshi00%2026-03-31
Board of Directors
NameDesignationYear
Mr. Sohan ChaturvediExecutive Director / Whole Time Director / CFO2025
Rajesh SadhwaniNon-Exec & Non-Independent Dir2025
Sneha SadhwaniNon-Exec & Non-Independent Dir2025
Siddhesh Shankar ShendeIndependent Non Exe. Director2025
Mayur Bharatbhai BhattIndependent Non Exe. Director2025
Sachin AphandkarIndependent Non Exe. Director2025
Hardik MakwanaCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Diagnostic Pharma Equipment₹33 Cr100%
Trading in Securities₹0 Cr0%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹1565555
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025600107
2025600006
2025000000
Substantial Acquisitions (SAST)

1 disclosure(s)

Rights Issue22/02/2024 · 4,60,00,000
Company Information
Incorporated1992
AuditorAbhishek S Tiwari & Associates
Investor Email[email protected]; [email protected]
🌐 www.genpharmasec.com ↗

📍 Office 104 & 105 1st Flr, Gundecha Indl Kandivali (East), Mumbai, Maharashtra, 400101

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Vas Infrastructure Ltd.KMF Builders & DevelopersBeryl Securities Ltd.Rap Corp LimitedDevine Impex Ltd.Bampsl Securities Ltd.Incon Engineers Ltd.Capri Global CapitalFDC Ltd.Gogia Capital Growth LimitedGorani Industries Ltd.KG Petrochem Ltd.All “53” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search